- Categories:R & D
- Time of issue:2021-08-18 10:10:14
Hubei Meilin Pharmaceutical Co., Ltd. was established in April 2010. It is a diversified compound pharmaceutical production company with self-research, production and sales, and joint research, production and sales. It is mainly engaged in the research and development and production of chemical raw materials and preparations. ,Sales.
The company is located in Yunmeng Economic Development Zone, Xiaogan City, Hubei Province, covering an area of 330 acres, with a construction area of about 23,000 square meters of production workshops and office buildings, with a total investment of 1 billion yuan and a registered capital of 80 million yuan.
The company has 26 national patents and more than 150 employees, including 25 persons with bachelor degree or above, 51 persons with college degree or above, and 38 persons with junior professional titles or above.
The construction of the industrial park project officially started on August 18, 2010. The construction of the project was completed in April 2012, and the second and third phases of capacity expansion were carried out in March 2018 and the end of 2019, respectively.
Now the company has plant facilities that meet GMP requirements, a sound quality management system, complete production equipment and inspection facilities. The supporting construction includes the second workshop for raw materials, the third workshop for raw materials, the nucleoside workshop, the boiler room, the comprehensive workshop, the chemical warehouse, the sewage treatment plant, etc. The company insists on introducing a quality risk management system from the product development stage, integrating quality management throughout the entire life cycle of the product to ensure the continuous and stable production of safe and effective qualified drugs. It has 8 preparation production lines, and the existing dosage forms include raw materials, tablets, hard capsules, granules, small-volume injections (including non-terminally sterilized small-volume injections), freeze-dried powder injections and large infusions. At present, the solid preparation production line and the raw materials (tripidil, triamterene, tolperidone hydrochloride, dilatrol hydrochloride, methyl salicylate) have passed GMP certification, and the raw materials (tripidil, triamterene hydrochloride, methyl salicylate) have passed GMP certification. Diazepam, tolperisone hydrochloride, ranitidine hydrochloride, methyl salicylate, delatrazol hydrochloride) have obtained record numbers. Compound amino acid granules and tripidil tablets have obtained drug approval numbers.
Since its establishment ten years ago, the company has been adhering to the business philosophy of "sharing, caring, cooperation, and sustainable development" and strengthening process management, committed to continuous improvement, pursuing high-quality, and meeting customer needs. Unanimously praised. And strive to become a large-scale pharmaceutical research and development, production, processing, and sales base in Hubei Province, inject new vitality into the development of the county economy, and contribute to the development of China's pharmaceuticals and human health!
Scan the QR code to read on your phone
Company address：No. 8 Heping Road, Economic Development Zone, Yunmeng County, Xiaogan, Hubei Postal code：432500 This website supports IPV6
Operation information: the website has been running for 00001 days. It is recommended to use the browser based on chromium core to browse the website at a resolution of no less than 1920 * 1280px to obtain good browsing effect.
Merriclin Official Website
Merriclin WeChat Official